UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 436

Sortiert nach

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

The lancet oncology, 2016-12, Vol.17 (12), p.1672-1682

2016

Link zum Volltext

Verfügbarkeit prüfen

Malignant Pleural Mesothelioma

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2081-2090

2009

Link zum Volltext

Verfügbarkeit prüfen

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1269-1283

2018

Link zum Volltext

Verfügbarkeit prüfen

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Journal of thoracic oncology, 2018-11, Vol.13 (11), p.1655-1667

2018

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

Head & neck oncology, 2010-06, Vol.2 (1), p.15-15, Article 15

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues

Scientific reports, 2021-02, Vol.11 (1), p.4530-4530, Article 4530

2021

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2013-02, Vol.8 (2), p.238-245

2013

Link zum Volltext

Verfügbarkeit prüfen

SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)

Journal of thoracic oncology, 2015-02, Vol.10 (2), p.387-391

2015

Link zum Volltext

Verfügbarkeit prüfen

Hemithoracic Intensity Modulated Radiation Therapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Survival Analysis

International journal of radiation oncology, biology, physics, 2015, Vol.91 (1), p.149-156

2015

Link zum Volltext

Verfügbarkeit prüfen

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

The Lancet (British edition), 2021-01, Vol.397 (10272), p.375-386

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations

Frontiers in oncology, 2023-08, Vol.13, p.1216999-1216999

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.1962-1972

2007

Link zum Volltext

Verfügbarkeit prüfen

Imatinib mesylate causes hypopigmentation in the skin

Cancer, 2003-12, Vol.98 (11), p.2483-2487

2003

Link zum Volltext

Verfügbarkeit prüfen

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Journal of clinical oncology, 2019-06, Vol.37 (18), p.1558-1565

2019

Link zum Volltext

Verfügbarkeit prüfen

A Mindfulness‐Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non‐Small Cell Lung Cancer and Their Spouses: Results of a Three‐Arm Pilot Randomized Controlled Trial

The oncologist (Dayton, Ohio), 2020-11, Vol.25 (11), p.e1794-e1802

2020

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy in Malignant Pleural Mesothelioma

International journal of radiation oncology, biology, physics, 2009-10, Vol.75 (2), p.326-337

2009

Link zum Volltext

Verfügbarkeit prüfen

New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options

Journal of clinical oncology, 2022-02, Vol.40 (6), p.681-692

2022

Link zum Volltext

Verfügbarkeit prüfen

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

The lancet oncology, 2017-09, Vol.18 (9), p.1261-1273

2017

Link zum Volltext

Verfügbarkeit prüfen

Current Readings: Window-of-Opportunity Trials for Thoracic Malignancies

Seminars in thoracic and cardiovascular surgery, 2014, Vol.26 (4), p.323-330

Tsao, Anne S., MD

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer

Journal of thoracic oncology, 2006-03, Vol.1 (3), p.231-239

2006

Link zum Volltext

Verfügbarkeit prüfen

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial

Cancer discovery, 2021-07, Vol.11 (7), p.1688-1699

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer

Cancer treatment and research communications, 2022-01, Vol.30, p.100514-100514, Article 100514

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 436

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(375)
Mit Volltextzugriff
(414)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(281)
Life Sciences & Biomedicine
(268)
Humans
(211)
Oncology
(165)
Female
(112)
Male
(109)
Respiratory System
(88)
Middle Aged
(86)
Aged
(65)
Adult
(63)
Lung Neoplasms - Drug Therapy
(52)
Biological And Medical Sciences
(49)
Medical Sciences
(40)
Lung Cancer
(38)
Lung Neoplasms - Pathology
(37)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(36)
Clinical & Internal Medicine
(36)
Treatment Outcome
(34)
Aged, 80 And Over
(32)
Animals
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Malignant Pleural Mesothelioma

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)

Hemithoracic Intensity Modulated Radiation Therapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Survival Analysis

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

Imatinib mesylate causes hypopigmentation in the skin

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

A Mindfulness‐Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non‐Small Cell Lung Cancer and Their Spouses: Results of a Three‐Arm Pilot Randomized Controlled Trial

Radiotherapy in Malignant Pleural Mesothelioma

New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

Current Readings: Window-of-Opportunity Trials for Thoracic Malignancies

Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial

Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer

Suchergebnisse filtern